04:21 PM EDT, 03/22/2024 (MT Newswires) -- Jennifer Kayden Lee, Executive Vice President, Head of North America, on March 20, 2024, sold 18,235 shares in Rhythm Pharmaceuticals ( RYTM ) for $707,005. Following the Form 4 filing with the SEC, Lee has control over a total of 6,852 shares of the company, with 6,852 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465924037880/xslF345X03/tm249484-1_4seq1.xml